secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioXcel Therapeutics, Inc. (BTAI)
CIK:        0001720893
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001104659-24-101689
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioXcel receives Nasdaq deficiency notices for bid price and market value; faces delisting risk
--------------------------------------------------------------------------------

- On Sep 16, 2024, Nasdaq notified BTAI that bid price closed below $1.00 for 30 consecutive business days.
- Company has until March 17, 2025 to regain compliance; stock must close at $1.00+ for 10 consecutive days.
- On Sep 20, 2024, Nasdaq notified BTAI that market value of listed securities fell below $35M minimum.
- Compliance deadline for market value is March 19, 2025; must meet $35M+ for 10 consecutive days.
- BTAI evaluating options; cannot assure regaining compliance; may be eligible for second 180-day period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720893/000110465924101689/0001104659-24-101689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720893/000110465924101689/tm2424352d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-101689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer